Viewing data from:

LACOSAMIDE

ANDA

LACOSAMIDE | A204921 | MSN LABORATORIES PRIVATE LTD

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: VIMPAT(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 8 NDCs

Highest NADAC/Unit

$0.2767

per ea

Lowest NADAC/Unit

$0.1108

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51991035105LACOSAMIDE 200 MG TABLET	$0.2767	EA	Generic	—	2026-06-17
51991035106LACOSAMIDE 200 MG TABLET	$0.2767	EA	Generic	—	2026-06-17
51991035005LACOSAMIDE 150 MG TABLET	$0.2075	EA	Generic	—	2026-06-17
51991035006LACOSAMIDE 150 MG TABLET	$0.2075	EA	Generic	—	2026-06-17
51991034905LACOSAMIDE 100 MG TABLET	$0.1716	EA	Generic	—	2026-06-17
51991034906LACOSAMIDE 100 MG TABLET	$0.1716	EA	Generic	—	2026-06-17
51991034805LACOSAMIDE 50 MG TABLET	$0.1108	EA	Generic	—	2026-06-17
51991034806LACOSAMIDE 50 MG TABLET	$0.1108	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs, 4 NC)

Lowest Price

$7.54

Highest Price

$16.90

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51407-0721-60LACOSAMIDE 50MG TAB	$7.54	NC	Golden State Medical Supply, Inc.	02/12/2027
51407-0722-60LACOSAMIDE 100MG TAB	$9.75	NC	Golden State Medical Supply, Inc.	02/12/2027
51407-0723-60LACOSAMIDE 150MG TAB	$14.75	NC	Golden State Medical Supply, Inc.	02/12/2027
51407-0724-60LACOSAMIDE 200MG TAB	$16.90	NC	Golden State Medical Supply, Inc.	02/12/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain33 active DMFs3 inactive

29 active API suppliers hold Drug Master Files for this ingredient.

HETERO DRUGS LTDLACOSAMIDE

DMF 261362012

SUN PHARMACEUTICAL INDUSTRIES LTDLACOSAMIDE USP

DMF 261742012

MSN PHARMACHEM PRIVATE LTDLACOSAMIDE USP [ROUTE CODE - "LD"]

DMF 262702012

APITORIA PHARMA PRIVATE LTDLACOSAMIDE (NON-STERILE DRUG SUBSTANCE)

DMF 263132012

ALIVUS LIFE SCIENCES LTDLACOSAMIDE USP

DMF 263232012

ALEMBIC PHARMACEUTICALS LTDLACOSAMIDE USP

DMF 263492012

TAPI NL BVLACOSAMIDE

DMF 263812012

CURIA MISSOURI INCLACOSAMIDE

DMF 263822012

ZYDUS LIFESCIENCES LTDLACOSAMIDE USP

DMF 264722012

SIGNA SA DE CVLACOSAMIDE

DMF 264842012

INTAS PHARMACEUTICALS LTDLACOSAMIDE

DMF 265202012

SYMPHONY PHARMA LIFESCIENCES PRIVATE LTDLACOSAMIDE

DMF 265942012

MACLEODS PHARMACEUTICALS LTDLACOSAMIDE

DMF 287972014

JUBILANT BIOSYS LTDLACOSAMIDE

DMF 291702015

INDOCO REMEDIES LTDLACOSAMIDE USP

DMF 294762015

CAMBREX PROFARMACO MILANO SRLLACOSAMIDE

DMF 297632015

HIKAL LTDLACOSAMIDE USP

DMF 303452016

UNICHEM LABORATORIES LTDLACOSAMIDE

DMF 324302018

CHIERON ACTIVE INGREDIENTS PRIVATE LTDLACOSAMIDE

DMF 335522019

BEIJING HOPE PHARMACEUTICAL CO LTDLACOSAMIDE

DMF 336782019

WISDOM PHARMACEUTICAL CO LTDLACOSAMIDE

DMF 341072019

MSN PHARMACHEM PRIVATE LTDLACOSAMIDE USP (ROUTE CODE-LS)

DMF 347372020

GLAND PHARMA LTDLACOSAMIDE

DMF 347842020

DIVIS LABORATORIES LTDLACOSAMIDE

DMF 357242021

INDOCO REMEDIES LTDLACOSAMIDE USP (PROCESS II)

DMF 367882022

EMNAR PHARMA PRIVATE LTDLACOSAMIDE USP

DMF 374462022

METROCHEM API PRIVATE LTDLACOSAMIDE USP

DMF 387892023

VIYASH LIFE SCIENCES PRIVATE LTDLACOSAMIDE USP

DMF 389782024

APITORIA PHARMA PRIVATE LTDLACOSAMIDE USP (PROCESS-II)

DMF 396502024

BEIJING HOPE PHARMACEUTICAL CO LTDLACOSAMIDE

DMF 400112024

CHROMO LABORATORIES INDIA PRIVATE LTDLACOSAMIDE USP

DMF 407342025

LEE PHARMA LTDLacosamide

DMF 419552025

LUNA CHEMICALS CO LTDLACOSAMIDE, NON-STERILE, BULK DRUG SUBSTANCE

DMF 432542025

DR REDDYS LABORATORIES LTDInactiveLACOSAMIDE

DMF 245992011

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveLACOSAMIDE

DMF 262502012

LUPIN MANUFACTURING SOLUTIONS LTDInactiveLACOSAMIDE

DMF 278352013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 4, 2020	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 50MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 17, 2022

No patent or exclusivity listings for this strength.

#002 — 100MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 17, 2022

#003 — 150MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 17, 2022

#004 — 200MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 17, 2022